About Sonal Gupta
Sonal Gupta is a chief medical officer at CoRegen.
Experience
This experience comes from Sonal Gupta's profile and from SEC filings. For roles taken from filings, the years are when the filings name Sonal Gupta in the role, so the role may have started earlier or lasted longer.
CoRegen, Inc. Current
Chief Medical Officer
2025 – Present · Houston, TX
Develops immune cell therapies for people with cancer.
AT
AffyImmune Therapeutics
Senior Vice President, Head of Clinical Development
2022 – 2025
AV
AVROBIO
Head of Translational Medicine at AvroBio
2020 – 2022
RT
Rubius Therapeutics
Senior Director, Head of Translational Research
2019 – 2020
CT
CRISPR Therapeutics
Director, Head of Preclinical and Clinical Assays
2016 – 2019
SB
Selecta Biosciences
Manager, Bioanalytical Group
2015 – 2016
CI
Cambridge Biomedical Inc.
Senior Research Scientist
2011 – 2015
SI
Shire Human Genetic Therapies Inc
Bioanalytical Assay Development Scientist
2009 – 2010
UB
University of Bradford
PhD student
2001 – 2004
GC
Government Medical College
Medical doctor
1993 – 1999
Key Colleagues at Startups
The people Sonal Gupta works with at each company, as listed on that company's latest Form D.
CoRegen, Inc. · Form D, Feb 26, 2026
JS
Jonathan Simons
Board Member
Steve Gorlin
Vice Chairman & President
BM
Bert O'Malley
Director
Suneet Varma
Chairman of the Board
WP
William Haseltine, PhD.
Director
Sonja Nelson
Chief Financial Officer
LF
Lee Fleisher
Board Member
EJ
Edward Benz, Jr.
Director
Peter Gelinas
Chief Technical Officer